About BBI Solutions
BBI Solutions is a company based in Crumlin (United Kingdom) founded in 1986 by John Chandler was acquired by Novo Holdings in June 2021. The company has 301 employees as of December 31, 2021. BBI Solutions has completed 2 acquisitions, including BioTeZ and Maine Biotechnology. BBI Solutions operates in a competitive market with competitors including Abcam, Stem Cell Technologies, Teknova, Meridian Bioscience and Sangon Biotech, among others.
- Headquarter Crumlin, United Kingdom
- Employees 301 as on 31 Dec, 2021
- Founders John Chandler
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bbi Solutions Oem Limited
- Date of Incorporation 21 Jan, 2013
- Jurisdiction CARDIFF
-
Annual Revenue
$50.63 M (USD)5as on Dec 31, 2020
-
Net Profit
$10.63 M (USD)17as on Dec 31, 2020
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
301
as on Dec 31, 2021
-
Investments & Acquisitions
BioTeZ
& 1 more
-
Acquired by
Novo Holdings
(Jun 15, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of BBI Solutions
Unlock access to complete
Funding Insights of BBI Solutions
Investors in BBI Solutions
BBI Solutions has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Novo Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location |
Investments & Acquisitions by BBI Solutions
BBI Solutions has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include BioTeZ and Maine Biotechnology.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Life science products and services are offered by BioTeZ.
|
1992 | ||||
|
Antibody design, development, and assay services are offered.
|
1990 |
Financial Statements - BBI Solutions
Bbi Solutions Comparisons
Competitors of BBI Solutions
BBI Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, Teknova, Meridian Bioscience and Sangon Biotech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological reagents and antibodies are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Developer of cell culture media and ancillary reagents for life science research
|
|
| domain | founded_year | HQ Location |
Molecular biology reagents and kits are supplied for research applications.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic device and kits
|
|
| domain | founded_year | HQ Location |
Research services, reagents, and kits for biotech applications are provided.
|
Frequently Asked Questions about BBI Solutions
BBI Solutions was founded in 1986.
BBI Solutions is headquartered in Crumlin, United Kingdom. It is registered at Crumlin, Northern Ireland, United Kingdom.
Mario Gualano is the current CEO of BBI Solutions.
As of Dec 31, 2021, the latest employee count at BBI Solutions is 301.
Annual revenue of BBI Solutions is $50.63M as on Dec 31, 2020.
BBI Solutions was founded in 1986 and is headquartered in Crumlin, United Kingdom. Operations focus on the life sciences sector, where immunoassays for research purposes are developed. A range of products is manufactured, including cell culture reagents, monoclonal and polyclonal antibodies, recombinant antigens, gold and silver nanoparticles, normal serums, and biothreat detection antibodies. These items support applications in research and diagnostics.
BBI Solutions's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
BBI Solutions has made 2 acquisitions, including BioTeZ, and Maine Biotechnology.
BBI Solutions has 1 investor. Key investors include Novo Holdings.